Vivek Kumar1, Ashok Kumar Yadav1, Sishir Gang2, Oommen John3, Gopesh K Modi4, Jai Prakash Ojha5, Rajendra Pandey6, Sreejith Parameswaran7, Narayan Prasad8, Manisha Sahay9, Santosh Varughese10, Seema Baid-Agarwal11, Vivekanand Jha1,3,12. 1. Department of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. 2. Muljibhai Patel Urological Hospital, Nadiad, India. 3. George Institute for Global Health, New Delhi, India. 4. Samarpan Kidney Institute and Research Center, Bhopal, India. 5. Department of Nephrology, Institute of Medical Science, Banaras Hindu University, Varanasi, India. 6. Department of Nephrology, Institute of Post Graduate Medical Education & Research, Kolkata, India. 7. Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry, India. 8. Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, India. 9. Department of Nephrology, Osmania Medical College, Osmania General Hospital, Hyderabad, India. 10. Department of Nephrology, Christian Medical College, Vellore, India. 11. Department of Nephrology and Transplant Center, Sahlgrenska University Hospital, Gothenburg, Sweden. 12. University of Oxford, Oxford, UK.
Abstract
AIM: The rate and factors that influence progression of chronic kidney disease (CKD) in developing countries like India are unknown. A pan-country prospective, observational cohort study is needed to address these knowledge gaps. METHODS: The Indian Chronic Kidney Disease (ICKD) study will be a cohort study of approximately 5000 patients with mild to moderate CKD presenting to centres that represent different geographical regions in India. Time to 50% decline in baseline estimated glomerular filtration rate, need of renal replacement therapy or any new cardiovascular disease (CVD) event or death from CVD are the primary end points. VALUE OF STUDY: This study will provide the opportunity to determine risk factors for CKD progression and development of CVD in Indian subjects and perform international comparisons to determine ethnic and geographical differences. A bio-repository will provide a chance to discover biomarkers and explore genetic risk factors.
AIM: The rate and factors that influence progression of chronic kidney disease (CKD) in developing countries like India are unknown. A pan-country prospective, observational cohort study is needed to address these knowledge gaps. METHODS: The Indian Chronic Kidney Disease (ICKD) study will be a cohort study of approximately 5000 patients with mild to moderate CKD presenting to centres that represent different geographical regions in India. Time to 50% decline in baseline estimated glomerular filtration rate, need of renal replacement therapy or any new cardiovascular disease (CVD) event or death from CVD are the primary end points. VALUE OF STUDY: This study will provide the opportunity to determine risk factors for CKD progression and development of CVD in Indian subjects and perform international comparisons to determine ethnic and geographical differences. A bio-repository will provide a chance to discover biomarkers and explore genetic risk factors.